Structural and functional interaction of fatty acids with human liver fatty acid-binding protein (L-FABP) T94A variant

FEBS Journal

Volumn 281, Issue 9, 2014, Pages 2266-2283

  Huang, Huan ^a   McIntosh, Avery L ^a   Martin, Gregory G ^a   Landrock, Kerstin K ^b   Landrock, Danilo ^b   Gupta, Shipra ^c   Atshaves, Barbara P ^c   Kier, Ann B ^b   Schroeder, Friedhelm ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Michigan State University   (United States)

Author keywords

fatty acids; L FABP; liver; PUFA; TG

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORT PROTEIN 5; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LIVER FATTY ACID BINDING PROTEIN; LONG CHAIN FATTY ACID; MONOUNSATURATED FATTY ACID; OLEIC ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEARIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN STRUCTURE; RAT; WILD TYPE;

FATTY ACIDS; L-FABP; LIVER; PUFA; TG;

ANILINO NAPHTHALENESULFONATES; ANIMALS; BLOTTING, WESTERN; CIRCULAR DICHROISM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; HUMANS; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; RATS; RECOMBINANT PROTEINS; SPECTROMETRY, FLUORESCENCE; TRIGLYCERIDES;

EID: 84899930784     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12780     Document Type: Article

References (103)

1. Martin GG, Danneberg H, Kumar LS, Atshaves BP, Erol E, Bader M, Schroeder F, &, Binas B, (2003) Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid binding protein (L-FABP) gene. J Biol Chem 278, 21429-21438.
2. Martin GG, Huang H, Atshaves BP, Binas B, &, Schroeder F, (2003) Ablation of the liver fatty acid binding protein gene decreases fatty acyl CoA binding capacity and alters fatty acyl CoA pool distribution in mouse liver. Biochemistry 42, 11520-11532.
3. Anstee QM, Daly AK, &, Day CP, (2011) Genetic modifiers of non-alcoholic fatty liver disease progression. Biochim Biophys Acta 1812, 1557-1566.
4. Bordewick U, Heese M, Borchers T, Robenek H, &, Spener F, (1989) Compartmentation of hepatic fatty-acid-binding protein in liver cells and its effect on microsomal phosphatidic acid biosynthesis. Biol Chem Hoppe-Seyler 370, 229-238.
5. Jolly CA, Hubbell T, Behnke WD, &, Schroeder F, (1997) Fatty acid binding protein: stimulation of microsomal phosphatidic acid formation. Arch Biochem Biophys 341, 112-121.
6. Jolly CA, Murphy EJ, &, Schroeder F, (1998) Differential influence of rat liver fatty acid binding protein isoforms on phospholipid fatty acid composition: phosphatidic acid biosynthesis and phospholipid fatty acid remodeling. Biochim Biophys Acta 1390, 258-268.
7. Schroeder F, Jolly CA, Cho TH, &, Frolov AA, (1998) Fatty acid binding protein isoforms: structure and function. Chem Phys Lipids 92, 1-25.
8. Hubbell T, Behnke WD, Woodford JK, &, Schroeder F, (1994) Recombinant liver fatty acid binding protein interactions with fatty acyl-coenzyme A. Biochemistry 33, 3327-3334.
9. Frolov A, Cho TH, Murphy EJ, &, Schroeder F, (1997) Isoforms of rat liver fatty acid binding protein differ in structure and affinity for fatty acids and fatty acyl CoAs. Biochemistry 36, 6545-6555.
10. McArthur MJ, Atshaves BP, Frolov A, Foxworth WD, Kier AB, &, Schroeder F, (1999) Cellular uptake and intracellular trafficking of long chain fatty acids. J Lipid Res 40, 1371-1383.
11. Jolly CA, Wilton DA, &, Schroeder F, (2000) Microsomal fatty acyl CoA transacylation and hydrolysis: fatty acyl CoA species dependent modulation by liver fatty acyl CoA binding proteins. Biochim Biophys Acta 1483, 185-197.
12. Yang SY, He XY, &, Schulz H, (1987) Fatty acid oxidation in rat brain is limited by the low activity of 3-ketoacyl-coenzyme A thiolase. J Biol Chem 262, 13027-13032.
13. Higuchi N, Kato M, Tanaka M, Miyazaki M, Takao S, Kohjima M, Kotoh K, Enjoji M, Nakamuta M, &, Takayanagi R, (2011) Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP, and L-FABP in non-alcoholic fatty liver disease. Exp Ther Med 2, 1077-1081.
14. Charlton M, Viker K, Krishnan A, Sanderson S, Veldt B, Kaalsbeek AJ, Kendrick M, Thompson G, Que F, Swain J, et al,. (2009) Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. Hepatology 49, 1375-1384.
15. Baumgardner JN, Shankar K, Hennings L, Badger TM, &, Ronis MJJ, (2007) A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. Am J Physiol Gastrointest Liver Physiol 294, G27-G38.
16. Martin GG, Atshaves BP, Huang H, McIntosh AL, Williams BW, Pai P-J, Russell DH, Kier AB, &, Schroeder F, (2009) Hepatic phenotype of liver fatty acid binding protein (L-FABP) gene ablated mice. Am J Physiol Gastrointest Liver Physiol 297, G1053-G1065.
17. Newberry EP, Xie Y, Kennedy S, Buhman KK, Luo J, Gross RW, &, Davidson NO, (2003) Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid binding protein gene. J Biol Chem 278, 51664-51672.
18. Newberry EP, Kennedy SM, Xie Y, Sternard BT, Luo J, &, Davidson NO, (2008) Diet-induced obesity and hepatic steatosis in L-FABP-/- mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation. Am J Physiol Gastrointest Liver Physiol 294, G307-G314.
19. Newberry EP, Kennedy SM, Xie Y, Luo J, Stanley SE, Semenkovich CF, Crooke RM, Graham MJ, &, Davidson NO, (2008) Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple muring genetic models. Hepatology 48, 1097-1105.
20. Xie Y, Newberry EP, Kennedy SM, Luo J, &, Davidson NO, (2009) Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice. J Lipid Res 50, 977-987.
21. Chen A, Tang Y, Davis V, Hsu F-F, Kennedy SM, Song H, Turk J, Brunt EM, Newberry EP, &, Davidson NO, (2013) L-FABP modulates murine stellate cell activation and diet induced nonalcoholic fatty liver disease. Hepatology 57, 2202-2212.
22. Guzman C, Benet M, Pisonero-Vaquero S, Moya M, Garcia-Mediavilla MV, Martinez-Chantar ML, Gonzalez-Gallego J, Castell JV, Sanchez-Campos S, &, Jover R, (2013) The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARa; and repressed by C/EBPa: implication in FABP1 down-regulation in nonalcoholic liver disease. Biochim Biophys Acta 1831, 803-818.
23. Rajaraman G, Wang GQ, Yan J, Jiang P, Gong Y, &, Burczynski FJ, (2007) Role of cytosolic liver fatty acid binding protein in hepatocellular oxidative stress: effect of dexamethasone and clofibrate treatment. Mol Cell Biochem 295, 27-34.
24. Wang G, Gong Y, Anderson J, Sun D, Minuk G, Robertes MS, &, Burczynski FJ, (2005) Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells. Hepatology 42, 871-879.
25. Wang G, Shen H, Rajaraman G, Roberts MS, Gong Y, Jiang P, &, Burczynski FJ, (2007) Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats. Eur J Pharmacol 560, 61-68.
26. Yan J, Gong Y, She Y-M, Wang G, Roberts MS, &, Burczynski FJ, (2009) Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity. J Lipid Res 50, 2445-2454.
27. Yan J, Gong Y, She YM, Wang G, Robertes MS, &, Burczynski FJ, (2010) Molecular mechanism of recombinant L-FABP's antioxidant activity. J Lipid Res 50, 2445-2454.
28. Smathers RL, Fritz KS, Galligan JJ, Shearn CT, Reigan P, Marks MJ, &, Petersen DR, (2012) Characterization of 4-HNE modified L-FABP reveals alterations in structural and functional dynamics. PLoS ONE 7, e38459.
29. Fan W, Chen K, Zheng G, Wang W, Teng A, Liu A, Ming D, &, Yan P, (2013) Role of liver fatty acid binding protein in hepatocellular injury: effect of CrPic treatment. J Inorg Biochem 124, 46-53.
30. Murphy EJ, Prows DR, Jefferson JR, &, Schroeder F, (1996) Liver fatty acid binding protein expression in transfected fibroblasts stimulates fatty acid uptake and metabolism. Biochim Biophys Acta 1301, 191-198.
31. Prows DR, Murphy EJ, &, Schroeder F, (1995) Intestinal and liver fatty acid binding proteins differentially affect fatty acid uptake and esterification in L-cells. Lipids 30, 907-910.
32. Murphy EJ, (1998) L-FABP and I-FABP expression increase NBD-stearate uptake and cytoplasmic diffusion in L-cells. Am J Physiol Gastrointest Liver Physiol 275, G244-G249.
33. Wolfrum C, Buhlman C, Rolf B, Borchers T, &, Spener F, (1999) Variation of liver fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake. Biochim Biophys Acta 1437, 194-201.
34. Atshaves BP, McIntosh AL, Lyuksyutova OI, Zipfel WR, Webb WW, &, Schroeder F, (2004) Liver fatty acid binding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes. J Biol Chem 279, 30954-30965.
35. McIntosh AL, Atshaves BP, Hostetler HA, Huang H, Davis J, Lyuksyutova OI, Landrock D, Kier AB, &, Schroeder F, (2009) Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator activated receptor-α activity in cultured primary hepatocytes. Arch Biochem Biophys 485, 160-173.
36. Storey SM, McIntosh AL, Huang H, Martin GG, Landrock KK, Landrock D, Payne HR, Kier AB, &, Schroeder F, (2012) Loss of intracellular lipid binding proteins differentially impacts saturated fatty acid uptake and nuclear targeting in mouse hepatocytes. Am J Physiol Gastrointest Liver Physiol 303, G837-G850.
37. McIntosh AL, Huang H, Atshaves BP, Wellburg E, Kuklev DV, Smith WL, Kier AB, &, Schroeder F, (2010) Fluorescent n-3 and n-6 very long chain polyunsaturated fatty acids: three photon imaging and metabolism in living cells overexpressing liver fatty acid binding protein. J Biol Chem 285, 18693-18708.
38. Lawrence JW, Kroll DJ, &, Eacho PI, (2000) Ligand dependent interaction of hepatic fatty acid binding protein with the nucleus. J Lipid Res 41, 1390-1401.
39. Huang H, Starodub O, McIntosh A, Kier AB, &, Schroeder F, (2002) Liver fatty acid binding protein targets fatty acids to the nucleus: real-time confocal and multiphoton fluorescence imaging in living cells. J Biol Chem 277, 29139-29151.
40. Huang H, Starodub O, McIntosh A, Atshaves BP, Woldegiorgis G, Kier AB, &, Schroeder F, (2004) Liver fatty acid binding protein colocalizes with peroxisome proliferator receptor α and enhances ligand distribution to nuclei of living cells. Biochemistry 43, 2484-2500.
41. Hostetler HA, McIntosh AL, Petrescu AD, Huang H, Atshaves BP, Murphy EJ, Kier AB, &, Schroeder F, (2010) Fluorescence methods to assess the impact of lipid binding proteins on ligand activated gene expression. In Methods in Lipid-Mediated Signaling (, Murphy EJ, &, Rosenberger TA, eds), pp. 299-348. CRC Press, Boca Raton, FL.
42. Wolfrum C, Borrmann CM, Borchers T, &, Spener F, (2001) Fatty acids and hypolipidemic drugs regulate PPARα and PPARγ gene expression via L-FABP: a signaling path to the nucleus. Proc Natl Acad Sci USA 98, 2323-2328.
43. Hostetler HA, McIntosh AL, Atshaves BP, Storey SM, Payne HR, Kier AB, &, Schroeder F, (2009) Liver type fatty acid binding protein (L-FABP) interacts with peroxisome proliferator activated receptor-α in cultured primary hepatocytes. J Lipid Res 50, 1663-1675.
44. Hostetler HA, Balanarasimha M, Huang H, Kelzer MS, Kaliappan A, Kier AB, &, Schroeder F, (2010) Glucose regulates fatty acid binding protein interaction with lipids and PPARa. J Lipid Res 51, 3103-3116.
45. Velkov T, (2013) Interactions between human liver fatty acid binding protein and peroxisome proliferator activated receptor drugs. PPAR Res 2013, 938401.
46. Smathers RL, Galligan JJ, Shearn CT, Fritz KS, Mercer K, Ronis M, Orlicky DJ, Davidson NO, &, Petersen DR, (2013) Susceptibility of L-FABP-/- mice to oxidative stress in early-stage alcoholic liver. J Lipid Res 54, 1335-1345.
47. Petrescu AD, Huang H, Martin GG, McIntosh AL, Storey SM, Landrock D, Kier AB, &, Schroeder F, (2012) Impact of L-FABP and glucose on polyunsaturated fatty acid induction of PPARa regulated β-oxidative enzymes. Am J Physiol Gastrointest Liver Physiol 304, G241-G256.
48. Robitaille J, Brouillette C, Lemieux S, Perusse L, Gaudet D, &, Vohl M-C, (2004) Plasma concentrations of apolipoprotein B are modulated by a gene-diet interaction effect between the L-FABP T94A polymorphism and dietary fat intake in French-Canadian men. Mol Genet Metab 82, 296-303.
49. Fisher E, Weikert C, Klapper M, Lindner I, Mohlig M, Spranger J, Boeing H, Schrezenmeir J, &, Doring F, (2007) L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. Mol Genet Metab 91, 278-284.
50. Weikert MO, Loeffelholz CV, Roden M, Chandramouli V, Brehm A, Nowotny P, Osterhoff MA, Isken F, Spranger J, Landau BR, et al,. (2007) A Thr94Ala mutation in human liver fatty acid binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucsoe levels in lipid-exposed subjects. Am J Physiol Endocrinol Metab 293, E1078-E1084.
51. Yamada Y, Kato K, Oguri M, Yoshida T, Yokoi K, Watanabe S, Metoki N, Yoshida H, Satoh K, Ichihara S, et al,. (2008) Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome. Int J Mol Med 21, 801-808.
52. Bu L, Salto LM, De Leon KJ, &, De Leon M, (2011) Polymorphisms in fatty acid binding protein 5 show association with type 2 diabetes. Diabetes Res Clin Pract 92, 82-91.
53. Peng X-E, Wu YL, Lu Q-Q, Ju Z-J, &, Lin X, (2012) Two genertic variants in FABP1 and susceptibility to non-alcoholic fatty liver disease in a Chinese population. Gene 500, 54-58.
54. Mansego ML, Martinez F, Martinez-Larrad MT, Zabena C, Rojo G, Morcillo S, Soriguer F, Martin-Escudero JC, Serrano-Rios M, Redon J, et al,. (2012) Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population. PLoS ONE 7, e31853.
55. Gao N, Qu X, Yan J, Huang Q, Yuan HY, &, Ouyang D-S, (2010) L-FABP T94A decreased fatty acid uptake and altered hepatic triglyceride and cholesterol accumulation in Chang liver cells stably transfected with L-FABP. Mol Cell Biochem 345, 207-214.
56. Brouillette C, Bose Y, Perusse L, Gaudet D, &, Vohl M-C, (2004) Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate. J Hum Genet 49, 424-432.
57. Masters JR, (2002) HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer 2, 315-319.
58. Nelson-Rees WA, &, Flandermeyer RR, (1976) HeLa cultures defined. Science 191, 96-98.
59. Masters JR, (2010) Cell line misidentification: the beginning of the end. Nat Rev Cancer 10, 441-448.
60. Cai J, Lucke C, Chen Z, Qiao Y, Klimtchuk E, &, Hamilton JA, (2012) Solution structure and backbone dynamics of human liver fatty acid binding protein: fatty acid binding revisited. Biophys J 102, 2585-2594.
61. Betts MJ, &, Russell RB, (2003) Amino acid properties and consequences of substitutions. In Bioinformatics for Geneticists (, Barnes MR, &, Gray IC, eds), pp. 289-316. John Wiley & Sons, New York.
62. Thompson J, Winter N, Terwey D, Bratt J, &, Banaszak L, (1997) The crystal structure of the liver fatty acid-binding protein. J Biol Chem 272, 7140-7150.
63. Cai J, Lucke C, Qiao Y, Klimtchuk E, &, Hamilton JA, (2010) Solution structure and backbone dynamics of human liver fatty acid binding protein. Biophys J 98, 238a.
64. Sharma A, &, Sharma A, (2011) Fatty acid induced remodeling within the human liver fatty acid binding protein. J Biol Chem 286, 31924-31928.
65. Zamyatin AA, (1972) Protein volume in solution. Prog Biophys Mol Biol 24, 107-123.
66. Chotia C, (1975) The nature of the accessible and buried surfaces of proteins. J Mol Biol 105, 1-14.
67. Ross JBA, Laws WR, Rousslang KW, &, Wyssbrod HR, (1992) Tyrosine fluorescence and phosphorescence from proteins and polypeptides. In Topics in Fluorescence Spectroscopy (, Lakowicz JR, ed), pp. 1-63. Plenum Press, New York.
68. He Y, Yang X, Wang H, Estephan R, Francis F, Kodukula S, Storch J, &, Stark RE, (2007) Solution-state molecular structure of apo and oleate-liganded liver fatty acid binding protein. Biochemistry 46, 12543-12556.
69. Chuang S, Velkov T, Horne J, Wielens J, Chalmers DK, Porter CJH, &, Scanlon MJ, (2009) Probing fibrate binding specificity of rat liver fatty acid binding protein. J Med Chem 52, 5344-5355.
70. Chuang S, Velkov T, Horne J, Porter CJH, &, Scanlon MJ, (2008) Characterization of the drug binding specificity of rat liver fatty acid binding protein. J Med Chem 51, 3755-3764.
71. Carbone V, &, Velkov T, (2013) Interaction of phthalates and phenoxy acid herbicide environmental pollutants with intestinal intracellular lipid binding proteins. Chem Res Toxicol 26, 1240-1250.
72. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, Mochizuki H, Bennett PH, Bogardus C, &, Prochazka M, (1995) An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95, 1281-1287.
73. Woodford JK, Behnke WD, &, Schroeder F, (1995) Liver fatty acid binding protein enhances sterol transfer by membrane interaction. Mol Cell Biochem 152, 51-62.
74. Schulenberg-Schell H, Schafer P, Keuper HJ, Stanislawski B, Hoffmann E, Ruterjans H, &, Spener F, (1988) Interactions of fatty acids with neutral fatty-acid-binding protein from bovine liver. Eur J Biochem 170, 565-574.
75. Thumser AE, Voysey J, &, Wilton DC, (1996) Mutations of recombinant rat liver fatty acid-binding protein at residues 102 and 122 alter its structural integrity and affinity for physiological ligands. Biochem J 314, 943-949.
76. Jakoby MG, Miller KR, Joner JJ, Bauman A, Cheng L, Li E, &, Cistola DP, (1993) Ligand-protein electrostatic interactions govern the specificity of retinol- and fatty acid-binding proteins. Biochemistry 32, 872-878.
77. Powell GL, Tippett PS, Kiorpes TC, McMillin-Wood J, Coll KE, Schultz H, Tanaka K, Kang ES, &, Shrago E, (1985) Fatty acyl CoA as an effector molecule in metabolism. Fed Proc 44, 81-84.
78. Atshaves BP, Martin GG, Hostetler HA, McIntosh AL, Kier AB, &, Schroeder F, (2010) Liver fatty acid binding protein (L-FABP) and dietary obesity. J Nutr Biochem 21, 1015-1032.
79. Evans C, &, Wilton DC, (1990) The chemical modification of cysteine-69 of rat liver fatty acid- binding protein (FABP): a fluorescence approach to FABP structure and function. Mol Cell Biochem 98, 135-140.
80. Thumser AE, Evans C, Worrall AF, &, Wilton DC, (1994) Effect on ligand binding of arginine mutations in recombinant rat liver fatty acid-binding protein. Biochem J 297, 103-107.
81. Hagan RM, Davies JK, &, Wilton DA, (2002) Effect of charge reversal mutations in the α-helical region of L-FABP on binding of fatty acyl CoAs, lysophospholipids, and bile acids. Mol Cell Biochem 239, 55-60.
82. Schroeder F, Petrescu AD, Huang H, Atshaves BP, McIntosh AL, Martin GG, Hostetler HA, Vespa A, Landrock K, Landrock D, et al,. (2008) Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids 43, 1-17.
83. Huang H, McIntosh AL, Martin GG, Petrescu AD, Landrock K, Landrock D, Kier AB, &, Schroeder F, (2013) Inhibitors of fatty acid synthesis induce PPARα-regulated fatty acid β-oxidative enzymes: synergistic roles of L-FABP and glucose. PPAR Res 2013, 865604.
84. Petrescu AD, McIntosh AL, Storey SM, Huang H, Martin GG, Landrock D, Kier AB, &, Schroeder F, (2013) High glucose potentiates liver fatty acid binding protein (L-FABP) mediated fibrate induction of PPARa in mouse hepatocytes. Biochim Biophys Acta 1831, 1412-1425.
85. Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T, Turk J, &, Semenkovich CF, (2005) 'New' hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 1, 309-322.
86. Hostetler HA, Lupas D, Tan Y, Dai J, Kelzer MS, Martin GG, Woldegiorgis G, Kier AB, &, Schroeder F, (2011) Acyl-CoA binding proteins interact with the acyl-CoA binding domain of mitochondrial carnitine palmitoyltransferase I. Mol Cell Biochem 355, 135-148.
87. Martin GG, McIntosh AL, Huang H, Gupta S, Atshaves BP, Kier AB, &, Schroeder F, (2013) Human liver fatty acid binding protein (L-FABP) T94A variant alters structure, stability, and interaction with fibrates. Biochemistry 52, 9347-9357.
88. Farruggia B, &, Pico GA, (1999) Thermodynamic features of the chemical and thermal denaturations of human serum albumin. Int J Biol Macromol 26, 317-323.
89. Wang Q, Christiansen A, Samiotakis A, Wittung-Stafshede P, &, Cheung MS, (2011) Comparison of chemical and thermal protein denaturation by combination of computational and experimental approaches II. J Chem Phys 135, 175102.
90. Veerkamp JH, van Moerkerk HT, Prinsen CF, &, Van Kuppevelt TH, (1999) Structural and functional studies on different human FABP types. Mol Cell Biochem 192, 137-142.
91. Long D, &, Yang D, (2010) Millisecond timescale dynamics of human liver fatty acid binding protein: testing of its relevance to the ligand entry process. Biophys J 98, 3054-3061.
92. Ray SS, &, Balaram P, (1999) 1-Anilino-8-naphthalene-sulfonate (ANS) binding to proteins investigated by electrospray ionization mass spectrometry: correlation of gas-phase dye binding to population of molten globule states in solution. J Phys Chem 103, 7068-7072.
93. Di Pietro SM, &, Santome JA, (2000) Isolation, characterization, and binding properties of two rat liver fatty acid binding protein isoforms. Biochim Biophys Acta 1478, 186-200.
94. Maatman RG, van Moerkerk HT, Nooren IM, van Zoelen EJ, &, Veerkamp JH, (1994) Expression of human liver fatty acid-binding protein in Escherichia coli and comparative analysis of its binding characteristics with muscle fatty acid-binding protein. Biochim Biophys Acta 1214, 1-10.
95. Lagakos WS, Guan X, Ho S-Y, Sawicki LR, Corsico B, Murota K, Stark RE, &, Storch J, (2013) L-FABP binds monoacylglycerol in vitro and in mouse liver cytosol. J Biol Chem 288, 19805-19815.
96. Storch J, (1993) Diversity of fatty acid-binding protein structure and function: studies with fluorescent ligands. Mol Cell Biochem 123, 45-53.
97. Hall AM, Kou K, Chen Z, Pietka TA, Kumar M, Korenblat KM, Lee K, Ahn K, Fabbrini E, Klein S, et al,. (2012) Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver. J Lipid Res 53, 990-999.
98. Schroeder F, Huang H, Hostetler HA, Petrescu AD, Hertz R, Bar-Tana J, &, Kier AB, (2005) Stability of fatty acyl CoA thioester ligands of hepatocyte nuclear factor-4α and peroxisome proliferator-activated receptor α. Lipids 40, 559-568.
99. Atshaves BP, Storey SM, Petrescu AD, Greenberg CC, Lyuksyutova OI, Smith R, &, Schroeder F, (2002) Expression of fatty acid binding proteins inhibits lipid accumulation and alters toxicity in L-cell fibroblasts. Am J Physiol Cell Physiol 283, C688-C703.
100. Weisiger RA, (2005) Cytosolic fatty acid binding proteins catalyze two distinct steps in intracellular transport of their ligands. Mol Cell Biochem 239, 35-42.
101. Jefferson JR, Powell DM, Rymaszewski Z, Kukowska-Latallo J, &, Schroeder F, (1990) Altered membrane structure in transfected mouse L-cell fibroblasts expressing rat liver fatty acid-binding protein. J Biol Chem 265, 11062-11068.
102. Schroeder F, Atshaves BP, Starodub O, Boedeker AL, Smith R, Roths JB, Foxworth WB, &, Kier AB, (2001) Expression of liver fatty acid binding protein alters growth and differentiation of embryonic stem cells. Mol Cell Biochem 219, 127-138.
103. Chao H, Zhou M, McIntosh A, Schroeder F, &, Kier AB, (2003) Acyl CoA binding protein and cholesterol differentially alter fatty acyl CoA utilization by microsomal acyl CoA: cholesterol transferase. J Lipid Res 44, 72-83.